For new health care investors particularly, America's five largest pharma stocks (Johnson & Johnson (NYSE:JNJ), Pfizer (NYSE:PFE), Merck (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY), and Eli Lilly (NYSE:LLY)) are a good place to start.
So, how do they stack up? in the video below, health care analysts Michael Douglass and David Williamson give their thoughts on the best investment opportunities among these five stocks.
Are these 5 top dividend stocks for the next decade?
One of the most exciting things about the five top American pharma stocks is that all of them pay a dividend. This is crucial because the smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.
David Williamson owns shares of Johnson & Johnson, Merck, and Pfizer. Michael Douglass has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.